5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine
C21H23F6N5 — CID 169153932
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine
5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine (PubChem CID 169153932) has the molecular formula C21H23F6N5 and a molecular weight of 459.44 g/mol. Its IUPAC name is 5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine.
Molecular Properties
| Compound Name | 5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine |
|---|---|
| PubChem CID | 169153932 |
| Molecular Formula | C21H23F6N5 |
| Molecular Weight | 459.44 g/mol |
| Exact Mass | 459.19 |
| IUPAC Name | 5-(2-aminoprop-1-enyl)-N-cyclohexyl-6-[2-(2,2,2-trifluoroethyl)-4-(trifluoromethyl)phenyl]-1,2,4-triazin-3-amine |
| SMILES | CC(N)=Cc1nc(NC2CCCCC2)nnc1-c1ccc(C(F)(F)F)cc1CC(F)(F)F |
| InChI | InChI=1S/C21H23F6N5/c1-12(28)9-17-18(31-32-19(30-17)29-15-5-3-2-4-6-15)16-8-7-14(21(25,26)27)10-13(16)11-20(22,23)24/h7-10,15H,2-6,11,28H2,1H3,(H,29,30,32) |
| InChIKey | AHPZKKAYXXPTRJ-UHFFFAOYSA-N |
| XLogP | 5.73 |
| TPSA | 76.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.44 |
| LogP ≤ 5 | 5.73 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169153932 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.